Analysis and Quantification of DNA Adducts of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in Liver of Rats by Liquid Chromatography/Electrospray Tandem Mass Spectrometry
- 9 March 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 15 (4) , 551-561
- https://doi.org/10.1021/tx010178e
Abstract
Liquid chromatography with electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) was used to measure DNA adducts of the carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) with a microbore C-18 reversed-phase column. Quantification of the isomeric adducts N-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-C8-MeIQx) and 5-(deoxyguanosin-N2-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-N2-MeIQx) was achieved using synthetic, isotopically labeled internal standards. The reaction of the N-acetoxy ester of 2-(hydroxyamino)-3,8-dimethylimidazo[4,5-f]quinoxaline (HONH-MeIQx) with calf thymus DNA (ct DNA) resulted in formation of these adducts in a ratio of 5:1 (dG-C8-MeIQx:dG-N2-MeIQx). The detection limit by LC/ESI-MS/MS in the selected reaction monitoring (SRM) mode ([MH+ → MH − 116]+) (loss of deoxyribose) approached 500 fg (1 fmol) of adduct standard, and 1 adduct per 108 DNA bases using 100 μg of DNA following solid-phase extraction. The SRM analysis of rat liver DNA 24 h after an oral dose of MeIQx (10 and 0.5 mg/kg) revealed the presence of isomeric dG-MeIQx adducts at levels of 3.07 ± 0.84 and 0.45 ± 0.27 adducts per 107 bases, respectively. LC/ESI-MS/MS product ion spectra were acquired on both adducts from the elevated dose of MeIQx for unambiguous adduct identification. The contribution of dG-N2-MeIQx to the total adducts in vivo was significantly more important than that observed in vitro. dG-C8-MeIQx was the principal adduct formed at the 10 mg/kg dose, (dG-C8-MeIQx:dG-N2-MeIQx (3:2)); however, dG-N2-MeIQx was the major lesion detected at the 0.5 mg/kg dose (dG-C8-MeIQx:dG-N2-MeIQx 1:10). The striking differences between the relative amounts of dG-C8-MeIQx and dG-N2-MeIQx formed in vivo as a function of dose suggest that reactive esters of HONH-MeIQx other than N-acetoxy-MeIQx may be formed in vivo and react preferentially with the N2 atom of guanine, or that dG-C8-MeIQx is removed at a significantly more rapid rate than dG-N2-MeIQx. The dG-N2-MeIQx adduct, previously thought to be a minor adduct, is likely to be an important contributor to the genotoxic damage of MeIQx.Keywords
This publication has 15 references indexed in Scilit:
- Quantification of the Heterocyclic Aromatic Amine DNA Adduct N-(Deoxyguanosin-8-yl)-2-amino-3-methylimidazo[4,5-f]quinoline in Livers of Rats Using Capillary Liquid Chromatography/Microelectrospray Mass Spectrometry: A Dose−Response StudyAnalytical Chemistry, 2001
- Formation and Differential Removal of C-8 and N2-Guanine Adducts of the Food Carcinogen 2-Amino-3-methylimidazo[4,5-f]quinoline in the Liver, Kidney, and Colorectum of the RatChemical Research in Toxicology, 1996
- 32P-Post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplificationCarcinogenesis: Integrative Cancer Research, 1994
- Identification of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f)quinoxaline 3',5'-diphosphate, a major DNA adduct, detected by nuclease P1 modification of the 32P-postlabeling method, in the liver of rats fed MeIQxCarcinogenesis: Integrative Cancer Research, 1993
- Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanineChemical Research in Toxicology, 1992
- DNA Adducts Formed by 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline in Rat Liver: Dose‐Response on Chronic AdministrationJapanese Journal of Cancer Research, 1990
- Successful use of short-term tests for academic purposes: Their use in identification of new environmental carcinogens with possible risk for humansMutation Research/Genetic Toxicology, 1988
- Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxalineCarcinogenesis: Integrative Cancer Research, 1988
- Metabolic activation of mutagenic heterocylic aromatic amines from protein pyrolysatesCRC Critical Reviews in Toxicology, 1986
- Formation and persistence of arylamine DNA adducts in vivo.Environmental Health Perspectives, 1985